ARCM is an independent research organization rooted in European culture. It was established in Toronto, Canada on April 20, 2022. Members of the organization have extensive college-level education in diverse scientific disciplines such as human biology, biochemistry, computer science, and immunology. The investment strategy employed by ARCM involves value investing and in-depth fundamental analysis, and is based on historical, scientific data and quantitative models.
Analysts revealed: I/we have no stock, option or similar derivatives positions in any of the companies mentioned and have no plans to initiate any such positions within the next 72 hours. This article was written by myself and expresses my own opinions. I received no compensation (other than from Seeking Alpha). I have no business relationships with any of the companies whose stock is mentioned in this article.
While we believe our research is reliable, there are always publications we may not have considered, which may cloud our judgement.
Seeking Alpha Disclosure: Past performance is no guarantee of future results. No advice or recommendation is given as to whether any investment is suitable for a particular investor. Any views or opinions stated above may not reflect the views of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or U.S. investment adviser or investment bank. Our analysts are third-party authors, including professional and individual investors, who may not be licensed or certified by any agency or regulatory body.
